The US government has announced the ten drugs selected for the first round of pricing negotiations under President Biden’s Inflation Reduction Act (IRA). The IRA allows Medicare, the government health ...

It’s the reason why many pharmaceutical companies are systemically re-evaluating the role of their field teams with a refreshed investment of skills and tools. A knowledgeable, skilled and engaging ...

CMS deputy administrator and director of the CMS Innovation Center, Liz Fowler, said the models would “test strategies to make it easier for Medicare patients to afford and access needed prescriptions ...

World Hepatitis Day takes place today, with this year’s theme, ‘I can’t wait’, highlighting the need to accelerate the fight against viral hepatitis to reach the 2030 elimination target. The campaign, ...

German company Merck KGaA has signed an exclusive licence agreement with Swiss biopharma company Debiopharm for its late-stage oncology asset xevinapant. Xevinapant is a potentially first-in-class ...

And Hope becomes a talent and administrative assistant responsible for assisting with the firm’s training, recruitment and HR. She moves to the agency from etc.venues, bringing experience in events ...

As technology advances there is a growing array of MedTech solutions – wearables, voice-activated devices, telehealth, etc. – to better support patients in their daily lives. However, MedTech research ...

AstraZeneca (AZ) and Merck’s – known as MSD outside the US and Canada – Lynparza (olaparib) has been recommended by the National Institute for Health and Care Excellence (NICE) as part of a ...

Gilead and EVOQ Therapeutics (EVOQ) have entered into a collaboration and licensing agreement aimed at advancing immunotherapies for the treatment of rheumatoid arthritis (RA) and lupus. Under the ...

Every day is different and the work so incredibly diverse. I sometimes don’t appreciate the true significance of what we are doing until I speak to a friend and tell them what I have been up to that ...

Professor Susan Short, co-author of the study from the University of Leeds, said: “We desperately need new treatment avenues for these aggressive brain tumours. Targeting developmental genes like the ...

Merck & Co – known as MSD outside the US and Canada – and Moderna have announced positive phase 2b trial results investigating the use of their personalised mRNA cancer vaccine, mRNA-4157/V940, in ...